GT Biopharma, Inc. announced that it has entered into agreements to exercise existing warrants for a total of 302,069 shares of its common stock at an exercise price of $4.35, which were issued in May ...
This aviation services leader reported a notable insider sale as shares continued to reflect strong performance over the past ...
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company developing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ...
TAMPA, Fla.--(BUSINESS WIRE)--American Integrity Insurance Group, Inc. (“American Integrity”) announced today that in connection with the previously announced initial public offering of 6,875,000 ...
Focused on rare liver disease therapies, this biopharma company reported a significant insider sale amid strong one-year stock gains.
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 7, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the ...
The filing relates to the sale or other disposition from time to time of (i) up to 21.66M shares of common stock issuable upon the exercise of ...
MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of ...
BOULDER, Colo., June 16, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback